Increasing prevalence of common diseases and conditions such as
obesity, diabetes, hypertension, etc., are leading to the risk of
various heart problems. Moreover, the rise in people suffering from
high blood pressure, and valvular heart disease due to the rheumatic
fever are some of the most common risk factors for atrial
fibrillation. Along with the increasing number of people suffering
from atrial fibrillation, especially among the geriatric population.
There has been an advancement in diagnoses and treatment of atrial
fibrillation. Researchers and experts are also working together to
find out new technologies to improve early detection and diagnosis of
atrial fibrillation and achieve maximum benefit for atrial
fibrillation patients. However, lack of well-trained physicians and
the high cost of treatments are hampering the atrial fibrillation
market growth.
Request for Sample Copy of Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1541
The report has provided a detailed profile of some of the leading
players in the global atrial fibrillation market such as Abbott
Laboratories, Biosense Webster, Inc., Medtronic Plc, MicroPort
Scientific Corporation, Boston Scientific Corporation, Biotronik SE &
Co. KG, CardioFocus, Inc., AtriCure Inc., Koninklijke Philips N.V.,
and Osypka AG.
According to a study by Transparency Market Research (TMR), the
global atrial fibrillation market is expected to witness strong
growth. The market is estimated to register 11.0% CAGR during the
forecast period 2017-2026. The market is also estimated to reach US$
10,925.1 million revenue by the end of 2026.
On the basis of product type, the EP ablation catheters are expected
to emerge as the most preferred product in the global atrial
fibrillation market. On the basis of end-user, the market is
segmented into electrophysiology labs, hospitals, and ambulatory
surgical center. Among these, hospitals are expected to be witness
impressive growth during the forecast period 2017-2026. By
application, EP ablation is expected to witness the highest growth in
the global atrial fibrillation market during the forecast period
2017-2026.
Enquiry for discount on this report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1541
Geographically, the market is segmented on the basis of North
America, Latin America, Europe, Japan, APEJ, and MEA. Europe is
expected to dominate the global atrial fibrillation market during the
forecast period 2017-2026. A maximum number of catheter ablation are
performed in Germany.
Major hospitals and medical centers are using a less invasive
procedure known as catheter ablation for treating atrial
fibrillation. It also has facilitated quick recovery than the
surgery. Meanwhile, the on-going research is also resulting in more
options that can be used by doctors to perform catheter ablation. A
recent study by the researchers at the Klinikum Coburg and the
University of Utah Health also showed that radiofrequency catheter
ablation lowered mortality rates in patients suffering from atrial
fibrillation. Being a highly effective therapy, various additional
features are being added to catheter ablation. For instance, new 3D
mapping technology reduces fluoroscopy time and radiation dose for
patients. Moreover, a new 3D catheter mapping technology allowing
real-time device tracking in prerecorded fluoroscopy was also being
used. However, new treatment options including FIRM ablation,
convergent procedure, and watchman device have also been developed
and were successful in minimizing the chances of atrial fibrillation.
Increasing demand for minimally invasive procedures and better
imaging is resulting in the manufacturers investing in research and
development for introducing technologically advanced catheter
ablation procedure. Meanwhile, increasing number of hospitals are
also using a combination of both device and drugs to treat atrial
fibrillation.
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment